Scarica l'app Stockscreener
6.83
0.15%
-0.010
Precedente Chiudi:
$6.84
Aprire:
$6.82
Volume 24 ore:
1.72M
Relative Volume:
0.73
Capitalizzazione di mercato:
$1.13B
Reddito:
$246.03M
Utile/perdita netta:
$-32.00M
Rapporto P/E:
-32.14
EPS:
-0.2125
Flusso di cassa netto:
$-16.78M
1 W Prestazione:
-4.87%
1M Prestazione:
-24.78%
6M Prestazione:
+38.82%
1 anno Prestazione:
+124.67%
Intervallo 1D:
$6.71
$6.935
Intervallo di 1 settimana:
$6.71
$7.4979
Portata 52W:
$3.02
$10.08
Xeris Biopharma Holdings Inc Stock (XERS) Company Profile
Nome
Xeris Biopharma Holdings Inc
Settore
Industria
Telefono
844-445-5704
Indirizzo
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL
Confronta XERS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XERS
Xeris Biopharma Holdings Inc
|
6.83 | 1.13B | 246.03M | -32.00M | -16.78M | -0.2125 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Xeris Biopharma Holdings Inc Stock (XERS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-12 | Ripresa | H.C. Wainwright | Buy |
| 2024-11-11 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-03-28 | Iniziato | Oppenheimer | Outperform |
| 2023-08-28 | Iniziato | Craig Hallum | Buy |
| 2022-10-21 | Iniziato | Jefferies | Buy |
| 2022-04-28 | Iniziato | Craig Hallum | Buy |
| 2021-11-17 | Iniziato | SVB Leerink | Outperform |
| 2021-10-29 | Iniziato | H.C. Wainwright | Buy |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Outperform |
| 2020-02-18 | Iniziato | Piper Sandler | Overweight |
| 2018-07-16 | Iniziato | Jefferies | Buy |
| 2018-07-16 | Iniziato | Leerink Partners | Outperform |
| 2018-07-16 | Iniziato | RBC Capital Mkts | Outperform |
Mostra tutto
Xeris Biopharma Holdings Inc Borsa (XERS) Ultime notizie
What drives Xeris Biopharma Holdings Inc 2B30 stock priceDividend Stability Analysis & Stay Safe With Built-In Risk Monitoring - earlytimes.in
Xeris Biopharma Faces Weak Start with 15% Gap Down Amid Market Concerns - Markets Mojo
How higher bond yields impact Xeris Biopharma Holdings Inc. (2B30) stockIndex Update & Accurate Entry/Exit Alerts - newser.com
Will Xeris Biopharma Holdings Inc. (2B30) stock hit Wall Street targetsPortfolio Value Summary & Low Drawdown Investment Ideas - newser.com
Will Xeris Biopharma Holdings Inc. stock deliver long term returns2025 Bull vs Bear & AI Powered Buy and Sell Recommendations - newser.com
Detecting support and resistance levels for Xeris Biopharma Holdings Inc.2025 Year in Review & Verified Stock Trade Ideas - newser.com
Why Xeris Biopharma Holdings Inc. (2B30) stock appeals to dividend investorsJuly 2025 Rallies & Daily Chart Pattern Signals - newser.com
What high frequency data says about Xeris Biopharma Holdings Inc.2025 Support & Resistance & Risk Controlled Swing Alerts - newser.com
How sentiment analysis helps forecast Xeris Biopharma Holdings Inc.Trade Volume Report & Long-Term Safe Investment Ideas - newser.com
Hecht Beth, chief legal officer, sells Xeris Biopharma (XERS) shares for $123k - Investing.com Nigeria
Officer Hecht Files To Sell 66,668 Of Xeris Biopharma Holdings Inc [XERS] - TradingView
Is Xeris Biopharma Holdings Inc. (2B30) stock supported by strong fundamentalsIPO Watch & Weekly Chart Analysis and Trade Guides - newser.com
Why Xeris Biopharma Holdings Inc. (2B30) stock is listed among top recommendationsTrade Signal Summary & Risk Adjusted Buy and Sell Alerts - newser.com
Is Xeris Biopharma Holdings Inc. (2B30) stock cheap vs fundamentalsJuly 2025 PreEarnings & Stepwise Entry and Exit Trade Signals - newser.com
Is a relief rally coming for Xeris Biopharma Holdings Inc. holdersStock Surge & Community Consensus Stock Picks - newser.com
Why Xeris Biopharma Holdings Inc. (2B30) stock could be top winnerWeekly Stock Summary & Daily Stock Trend Reports - newser.com
Is Xeris Biopharma Holdings Inc. stock entering bullish territoryJuly 2025 Review & Risk Controlled Stock Alerts - newser.com
Applying chart zones and confluence areas to Xeris Biopharma Holdings Inc.Oil Prices & Consistent Growth Equity Picks - newser.com
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year - Yahoo Finance
Q4 2024 Xeris Biopharma Holdings Inc Earnings Call Transcript - GuruFocus
Xeris Biopharma (XERS) Turns Profitable and Lifts 2025 Outlook but What Will Sustain Growth? - Sahm
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q3 2025 Earnings Call Transcript - Insider Monkey
Xeris raises 2025 revenue guidance to $285M-$290M as RECORLEV revenue more than doubles year-over-year - MSN
Xeris Biopharma Holdings, Inc. (2B30.F) stock price, news, quote and history - Yahoo Finance Singapore
Xeris Biopharma Hits Day Low at $7.00 Amid Price Pressure - Markets Mojo
Xeris Biopharma Holdings Inc (XERS) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
Xeris Biopharma Posts Record Financial Results for the Third Quarter 2025 - BioSpace
Assessing Xeris Biopharma (XERS) Valuation Following Strong Q3 Earnings and Raised Revenue Guidance - simplywall.st
Xeris Biopharma Reports Strong Q3 2025 Financial Results - TipRanks
Xeris Biopharma (XERS) Reports Q3 Earnings: What Key Metrics Have to Say - sharewise.com
Xeris Biopharma (XERS) Reports Break-Even Earnings for Q3 - sharewise.com
Xeris Biopharma Holdings Inc (XERS) Q3 2025 Earnings Call Highli - GuruFocus
Xeris Biopharma Holdings Inc Azioni (XERS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):